[Hair growth disorders following sex hormone treatment--therapy of hair growth disorders using sex hormones].
D000505:Alopecia / Q000139:chemically induced* / Q000188:drug therapy; D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000728:Androgens / Q000009:adverse effects / Q000627:therapeutic use; D002715:Chlormadinone Acetate / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use; D003534:Cyproterone / Q000009:adverse effects / Q000627:therapeutic use; D004967:Estrogens / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use; D005260:Female; D012739:Gonadal Steroid Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D006628:Hirsutism / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male
D045930:Anabolic Agents; D000728:Androgens; D003276:Contraceptives, Oral; D004967:Estrogens; D012739:Gonadal Steroid Hormones; D002715:Chlormadinone Acetate; D003534:Cyproterone
Haarwuchsstörungen nach Sexualhormontherapie--Sexualhormontheapie bei Haarwuchsstörungen.